How protein coronas determine the fate of engineered nanoparticles in biological environment

1. Saptarshi SR, Duschl A, Lopata AL. Interaction of nanoparticles with proteins: relation to bio-reactivity of the nanoparticle. J Nanobiotechnol 2013;11:26. doi: 10.1186/1477-3155-11-26Search in Google Scholar

2. Huang R, Carney RP, Stellacci F, Lau BL. Proteinnanoparticle interactions: the effects of surface compositional and structural heterogeneity are scale dependent. Nanoscale 2013;5:6928-35. doi: 10.1039/c3nr02117cSearch in Google Scholar

3. Jurašin DD, Ćurlin M, Capjak I, Crnković T, Lovrić M, Babič M, Horák D, Vinković Vrček I, Gajović S. Sufrace coating affects behavior of metallic nanoparticle in a bilogical environment. Beilstein J Nanotechnol 2016;7:246-62. doi: 10.3762/bjnano.7.23.Search in Google Scholar

4. European Commission. Commission recommendation of 18 October 2011 on the definition of nanomaterial (Text with EEA relevance) (2011/696/EU) [displayed 3 November 2017]. Available at https://ec.europa.eu/research/industrial_technologies/pdf/policy/commission-recommendation-onthe-definition-of-nanomater-18102011_en.pdfSearch in Google Scholar

5. Lane LA, Qian X, Smith AM, Nie S. Physical chemistry of nanomedicine: understanding the complex behaviours of nanoparticles in vivo. Annu Rev Phys Chem 2015;66:521-47. doi: 10.1146/annurev-physchem-040513-103718Search in Google Scholar

6. Ding F, Radic S, Chen R, Chen P, Geitner NK, Brown JM, Ke PC. Direct observation of a single nanoparticle-ubiquitin corona formation. Nanoscale 2013;5:9162-9. doi: 10.1039/ c3nr02147eSearch in Google Scholar

7. Duran N, Silveira CP, Duran M, Martinez DST. Silver nanoparticle protein corona and toxicity: a mini-review. J Nanobiotechnology 2015;13:55. doi: 10.1186/s12951-015-0114-4Search in Google Scholar

8. Docter D, Westmeier D, Markiewicz M, Stolte S, Knauer SK, Stauber RH. The nanoparticle biomolecule corona: lessons learned - challenge accepted? Chem Soc Rev 2015;44:6094-121. doi: 10.1039/C5CS00217FSearch in Google Scholar

9. Kononenko V, Narat M, Drobne D. Nanoparticle interaction with the immune system. Arh Hig Rada Toksikol 2015;66:97-108. doi:10.1515/aiht-2015-66-2582 Search in Google Scholar

10. Nel AE, Mädler L, Velegol D, Xia T, Hoek EMV, Somasundaran P, Klaessig F, Castranova V, Thompson M. Understanding biophysicochemical interactions at the nanobio interface. Nat Mater 2009;8:543-57. doi: 10.1038/nmat2442Search in Google Scholar

11. Tavanti F, Pedone A, Menziani MC. Competitive binding of proteins to gold nanoparticles disclosed by molecular dynamics simulations. J Phys Chem C 2015;119:22172-80. doi: 10.1021/acs.jpcc.5b05796Search in Google Scholar

12. Cedervall T, Lynch I, Foy M, Berggad T, Donnelly S, Cagney G, Linse S, Dawson K. Detailed identification of plasma proteins adsorbed on copolymer nanoparticles. Angew Chem Int Ed 2007;46:5754-6. doi: 10.1002/anie.200700465Search in Google Scholar

13. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci 2008;105:14265-70. doi: 10.1073/pnas.0805135105Search in Google Scholar

14. Cedervall T, Lynch I, Lindman S, Berggård T, Thulin E, Nilsson H, Dawson KA, Linse S. Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles. Proc Natl Acad Sci USA 2007;104:2050-5. doi: 10.1073/pnas.0608582104Search in Google Scholar

15. Lynch I, Dawson KA, Linse S. Detecting cryptic epitopes created by nanoparticles. Sci STKE 2006;2006(327):pe14. doi: 10.1126/stke.3272006pe14Search in Google Scholar

16. Gref R, Lück M, Quellec P, Marchand M, Dellacherie E, Harnisch S, Blunk T, Müller RH. ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 2000;18:301-13. doi: 10.1016/S0927-7765(99)00156-3Search in Google Scholar

17. Kittler S, Greulich C, Gebauer JS, Diendorf J, Treuel L, Ruiz L, Gonzalez-Calbet JM, Vallet-Regi M, Zellner R, Köller M, Epple M. The influence of proteins on the dispersability and cell-biological activity of silver NP. J Mater Chem 2010;20:512-8. doi: 10.1039/B914875BSearch in Google Scholar

18. Koshkina O, Lang T, Thiermann R, Docter D, Stauber RH, Secker C, Schlaad H, Weidner S, Mohr B, Maskos M, Bertin A. Temperature-triggered protein adsorption on polymercoated nanoparticles in serum. Langmuir 2015;31:8873-81. doi: 10.1021/acs.langmuir.5b00537Search in Google Scholar

19. Monopoli MP, Walczyk D, Campbell A, Elia G, Lynch I, Bombelli FB, Dawson KA. Physical-chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles. J Am Chem Soc 2011;133:2525-34. doi: 10.1021/ja107583hSearch in Google Scholar

20. Miclăuş T, Bochenkov VE, Ogaki R, Howard KA, Sutherland DS. Spatial mapping and quantification of soft and hard protein coronas at silver nanocubes. Nano Lett 2014;14:2086-93. doi: 10.1021/nl500277cSearch in Google Scholar

21. Walkey CD, Chan WC. Understanding and controlling the interaction of nanomaterials with proteins in a physiological environment. Chem Soc Rev 2012;41:2780-99. doi: 10.1039/ c1cs15233eSearch in Google Scholar

22. Vroman L, Adams AL, Fischer GC, Munoz PC. Interaction of high molecular-weight kininogen, factor-XII, and fibrinogen in plasma at interfaces. Blood 1980;55:156-9. PMID: 735093510.1182/blood.V55.1.156.bloodjournal551156Search in Google Scholar

23. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev 2009;61:428-37. doi: 10.1016/j.addr.2009.03.009Search in Google Scholar

24. Göppert TM, Müller RH. Polysorbate-stabilized solid lipid nanoparticles as colloidal carriers for of drugs to the brain: comparison of plasma protein adsorption patterns. J Drug Target 2005;13:179-87. doi: 10.1080/10611860500071292Search in Google Scholar

25. Gebauer JS, Malissek M, Simon S, Knauer SK, Maskos M, Stauber RH, Peukert W, Treuel L. Impact of the nanoparticleprotein corona on colloidal stability and protein structure. Langmuir 2012;28:9673-9. doi: 10.1021/la301104aSearch in Google Scholar

26. Treuel L, Nienhaus GU. Toward a molecular understanding of nanoparticle-protein interactions. Biophys Rev 2012;4:137-47. doi 10.1007/s12551-012-0072-010.1007/s12551-012-0072-0541838228510093Open DOISearch in Google Scholar

27. Lynch I, Dawson KA, Linse S. Detecting cryptic epitopes created by nanoparticles. Sci STKE 2006;2006(327):pe14. doi: 10.1126/stke.3272006pe14Search in Google Scholar

28. Walczyk D, Bombelli FB, Monopoli MP, Lynch I, Dawson KA. What the cell “sees” in bionanoscience. J Am Chem Soc 2010;132:5761-8. doi: 10.1021/ja910675vSearch in Google Scholar

29. Gessner A, Waicz R, Lieske A, Paulke B-R, Mäder K, Müller RH. Nanoparticles with decreasing surface hydrophobicities: influence on plasma protein adsorption. Int J Pharm 2000;196:245-9. doi: 10.1016/S0378-5173(99)00432-9Search in Google Scholar

30. Lundqvist M, Stigler J, Cedervall T, Berggard T, Flanagan MB, Lynch I, Elia G, Dawson K. The evolution of the protein corona around nanoparticles: a test study. ACS Nano 2011;5:7503-9. doi: 10.1021/nn202458gSearch in Google Scholar

31. Mahmoudi M, Lynch I, Ejtehadi MR, Monopoli MP, Bombelli FB, Laurent S. Protein-nanoparticle interactions: opportunities and challenges. Chem Rev 2011;111:5610-37. doi: 10.1021/cr100440gSearch in Google Scholar

32. Klein J. Probing the interaction of proteins and nanoparticles. Proc Natl Acad Sci USA 2007;104:2029-30. doi: 10.1073/ pnas.0611610104Search in Google Scholar

33. Gessner A, Lieske A, Paulke BR, Müller RH. Influence of surface charge density on protein adsorption on polymeric nanoparticles: analysis by two-dimensional electrophoresis. Eur J Pharm Biopharm 2002;54:165-70. doi: 10.1016/S0939-6411(02)00081-4Search in Google Scholar

34. Lindman S, Lynch I, Thulin E, Nilsson H, Dawson KA, Linse S. Systematic investigation of the thermodynamics of HSA adsorption to N-iso-propylacrylamide/N-tert-butylacrylamide copolymer nanoparticles. Effects of particle size and hydrophobicity. Nano Lett 2007;7:914-20. doi: 10.1021/nl062743+Search in Google Scholar

35. Rahman M. Nanoparticle and protein corona. In: Rahman M, Laurent S, Tawil N, Yahia L, Mahmoudi M, editors. Springer Series in Biophysics. Vol. 15. Protein-nanoparticle interactions. Chapter 2. Berlin Heidelberg: Springer-Verlag; 2013. p. 21-44.10.1007/978-3-642-37555-2_2Search in Google Scholar

36. Fleischert CC, Payne CK. Nanoparticle-cell interactions: molecular structure of the protein corona and cellular outcomes. Acc Chem Res 2014;47:2651-9. doi: 10.1021/ ar500190qSearch in Google Scholar

37. Laera S, Ceccone G, Rossi F, Gilliland D, Hussain R, Siligardi G, Calzolai L. Measuring protein structure and stability of protein-nanoparticle systems. Nano Lett 2011;11:4480-4. doi: 10.1021/nl202909sSearch in Google Scholar

38. Eskandari K, Kamali M, Ramezani M, Safiri Z, Keihan AH, Rashidiani J, Kooshki H, Zarei H. The effect of hydrophobicity and hydrophilicity of gold nanoparticle on proteins structure and function. Int J Bio-Inorg Hybrid Nanomat 2013;2:465-70.Search in Google Scholar

39. Cui M, Liu R, Deng Z, Ge G, Liu Y, Xie L. Quantitative study of protein coronas on gold nanoparticles with different surface modifications. Nano Res 2013;7:345. doi: 10.1007/ s12274-013-0400-0Search in Google Scholar

40. Boulos SP, Davis TA, Yang JA, Lohse SE, Alkilany AM, Holland LA, Murphy CJ. Nanoparticle-protein interactions: a thermodynamic and kinetic study of the adsorption of bovine serum albumin to gold nanoparticle surfaces. Langmuir 2013;29:14984-96. doi: 10.1021/la402920fSearch in Google Scholar

41. Sakulkhu U, Mahmoudi M, Maurizi L, Salaklang J, Hofmann H. Protein corona composition of superparamagnetic iron oxide nanoparticles with various physico-chemical properties and coatings. Scientific Rep 2014;4:5020. doi: 10.1038/srep05020Search in Google Scholar

42. Karmali PP, Simberg D. Interactions of nanoparticles with plasma proteins: implication on clearance and toxicity of drug delivery systems. Expert Opin Drug Deliv 2011;8:343-57. doi: 10.1517/17425247.2011.554818Search in Google Scholar

43. Lee YK, Choi E-J, Webster TJ, Kim S-H, Khang D. Effect of the protein corona on nanoparticles for modulating cytotoxicity and immunotoxicity. Int J Nanomedicine 2015;10:97-113. doi: 10.2147/IJN.S72998Search in Google Scholar

44. Yallapu MM, Ebeling MC, Jaggi M, Chauhan SC. Plasma proteins interaction with curcumin nanoparticles: implications in cancer therapeutics. Curr Drug Metab 2013;14:504-15. PMCID: PMC403072710.2174/1389200211314040012403072723566382Open DOISearch in Google Scholar

45. Zook JM, Halter MD, Cleveland D, Long SE. Disentangling the effects of polymer coatings on silver nanoparticle agglomeration, dissolution and toxicity to determine mechanisms of nanotoxicity. J Nanopart Res 2012;14:1165. doi: 10.1007/s11051-012-1165-1Search in Google Scholar

46. Shannahan JH, Lai X, Ke PC, Podila R, Brown JM, Witzmann FA. Silver nanoparticle protein corona composition in cell culture media. PLoS One 2013;8:e74001. doi: 10.1371/journal.pone.0074001Search in Google Scholar